Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FVJA5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,300
Award facts
- Contract value 100% obligated
- $62,299.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $62,299.59 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, functions as a critical federal medical procurement vendor specializing in pharmaceutical products and medical supplies for military and veteran healthcare systems. The company's existing contract portfolio with the Defense Logistics Agency demonstrates extensive experience delivering a broad spectrum of medications, including specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. This Zepbound delivery order reflects the company's ongoing role as a primary supplier within the Defense Health Agency's pharmaceutical supply chain, supporting the administration's strategic medical procurement objectives for federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FVJA5?
SPE2DB25FVJA5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FVJA5 worth?
The government has obligated $62,300 on SPE2DB25FVJA5.
Is contract SPE2DB25FVJA5 an order under another contract?
Yes. SPE2DB25FVJA5 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVJA5 competed?
The extent of competition for SPE2DB25FVJA5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award